- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
Contents
What is the News?
The US Food and Drug Administration has issued an emergency use authorization for the Covid-19 test named InspectIR COVID-19 Breathalyzer.
What is InspectIR COVID-19 Breathalyzer?
It is the first testing device that can detect COVID-19 in the breath samples of humans.
How does the test device work?
The device uses a technique called gas chromatography gas mass-spectrometry (GC-MS) to separate and identify chemical mixtures and rapidly detect five Volatile Organic Compounds (VOCs) associated with SARS-CoV-2 infection in exhaled breath.
When the device detects the presence of VOC markers of SARS-CoV-2, a presumptive (unconfirmed) positive test result is returned and should be confirmed with a molecular test.
Significance of this device
Firstly, this device is about the size of a piece of carry-on luggage and can be used in doctor’s offices, hospitals and mobile testing sites.
Secondly, the device can provide results in less than three minutes.
source: This post is based on the article “FDA authorizes first breath test for Covid” published in The Hindu on 16th April 2022.
